Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Clinical Medicine (London, England)|January 25, 2013
Cardiac disease in pregnancySurabhi Nanda, Catherine Nelson-Piercy, Lucy Mackillop
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 17, 2020
Antenatal management of multiple pregnancies within the UK: A survey of practiceJoanna Gent, Surabhi Nanda, Asma Khalil, et al.
Fetal Diagnosis and Therapy|February 5, 2011
Maternal serum adiponectin at 11-13 weeks of gestation in pregnancies delivering small for gestation neonatesSurabhi Nanda, Ranjit Akolekar, Danielle Sodre, et al.
Prenatal Diagnosis|January 27, 2011
Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeksSurabhi Nanda, Mina Savvidou, Argyro Syngelaki, et al.
Prenatal Diagnosis|March 12, 2011
Maternal serum adiponectin at 11 to 13 weeks of gestation in the prediction of macrosomiaSurabhi Nanda, Ranjit Akolekar, Rita Sarquis, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 24, 2023
Fetal growth restriction: How reliable is information available to patients on Google? A systematic reviewMegan Hall, Lindsay Wu, Surabhi Nanda, et al.
Metabolism: Clinical and Experimental|February 16, 2013
Maternal serum retinol-binding protein-4 at 11-13 weeks' gestation in normal and pathological pregnanciesSurabhi Nanda, George Nikoletakis, Desislava Markova, et al.
Fetal Diagnosis and Therapy|January 27, 2011
Maternal serum adiponectin at 11-13 weeks of gestation in preeclampsiaSurabhi Nanda, Christina K H Yu, Laura Giurcaneanu, et al.
Hematology (Amsterdam, Netherlands)|October 23, 2018
Maternal sickle cell disease and twin pregnancy: a case series and review of the literatureDeyna Cardosa, Alexandra Ridout, Surabhi Nanda, et al.
Metabolism: Clinical and Experimental|December 8, 2011
Maternal serum resistin at 11 to 13 weeks' gestation in normal and pathological pregnanciesSurabhi Nanda, Leona C Y Poon, Mazen Muhaisen, et al.
Pageof 3